Lifestyle is more important than genes: Nature study on longevity https://ymaho.com/lifestyle-is-more-important-than-genes-nature-study-on-longevity
Habits reduce the risk of death by 40.7%, while genes only by 13%, scientists have proven. Learn how to offset poor heredity and extend life after 80 years.
Cardiologist Topol debunks myths of the anti-aging industry https://ymaho.com/cardiologist-topol-debunks-myths-of-the-anti-aging-industry
Eric Topol proved: there are no longevity genes, and the $85 billion anti-aging market is overvalued. Find out why lifestyle and AI prevention are more important than peptides and cryochambers.
evoCAST: gene insertion without DNA cuts — breakthrough 2026 https://ymaho.com/evocast-gene-insertion-without-dna-cuts-breakthrough-2026
The new evoCAST tool inserts whole genes without double-strand breaks. Efficiency increased 400-fold. Learn how this will change gene therapy.
AI-designed viral vectors: 50-fold increase in gene delivery to the brain https://ymaho.com/ai-designed-viral-vectors-50-fold-increase-in-gene-delivery-to-the-brain
WhiteLab Genomics created AAV vectors with AI that deliver genes to the mouse brain 50 times more efficiently and accumulate less in the liver. Learn about the breakthrough in gene therapy.
Smart drugs for cancer and HIV: development by Siberian scientists https://ymaho.com/smart-drugs-for-cancer-and-hiv-development-by-siberian-scientists
Institute of the Siberian Branch of the Russian Academy of Sciences creates therapeutic oligonucleotides — molecules that switch off cancer and HIV genes. The development of phosphorylguanidines promises treatment without side effects. Learn how Russian genetic engineering bypasses Western patents.
RNA editing with light: CRISPR/Cas13d for deep tissues https://ymaho.com/rna-editing-with-light-crispr-cas13d-for-deep-tissues
Scientists created a photoactivatable system paCas13d with nanoparticles. The technology cured bone necrosis in mice without harming systemic therapy. Learn how IR light controls genes at tissue depth.
FDA approved the first gene therapy for hereditary deafness https://ymaho.com/fda-approved-the-first-gene-therapy-for-hereditary-deafness
Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.
Gene therapy against aging: Russian RNA drugs block RAGE https://ymaho.com/gene-therapy-against-aging-russian-rna-drugs-block-rage
Scientists from Russia are creating the world's first gene therapeutic drug for aging: a RAGE gene blocker and exosomes against sarcopenia. Learn how the state project promises to restore muscles and prolong active life.
Gene therapy of aging in the Russian Federation: RAGE blockade and sarcopenia exosomes https://ymaho.com/gene-therapy-of-aging-in-the-russian-federation-rage-blockade-and-sarcopenia-exosomes
Russian scientists are creating the world's first anti-aging drugs: RAGE gene blocker and exosome rejuvenation. The Ministry of Education and Science promises clinical use by 2030. Learn how transplantation of 'young' vesicles restores muscles and why the budget exceeds 2 trillion rubles.
In vivo gene editing: CRISPR therapy for hereditary angioedema https://ymaho.com/in-vivo-gene-editing-crispr-therapy-for-hereditary-angioedema
Single-dose CRISPR therapy NTLA-2002 reduced hereditary angioedema attacks by 87% in phase III. Learn how this will change treatment and pave the way to a cure.